# hey-skelly!-I-would-love-to-talk-with-you-about-the-current-methods-being-uses-to-diagnose-adn-treat

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212468087048241183) 

 Tracking biomarkers for multiple myeloma commonly involves:

- **Selection of Biomarkers**: Determined through clinical research that identifies indicators of disease activity, such as M-protein levels, light chains ratio, and others.
- **Machine Learning Advantages**: ML enhances this process by handling complex, multi-dimensional data and identifying subtle patterns that may indicate changes in the disease state.

To improve interpretability:

- **Feature Importance**: Highlight which biomarkers are most influential in the model's predictions.
- **Model Visualization**: Create tools that visually map the relationship between biomarker levels and the model's output.
- **Clinical Context Integration**: Ensure model outputs are presented in a context that makes sense to clinicians, possibly by mapping predictions to clinically relevant outcomes or thresholds.

Your contribution could be developing a framework that incorporates these aspects to make ML models more user-friendly for healthcare professionals.

## **ellie0237**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212468085538422884) 

 I want to look into tracking biomarkers, how was it deteremined which biomarkers to look for and how has machine learning made it easier? also how can i help imporve interpretability of the outputted models?

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212467197343961088) 

 Focusing on the monitoring stage is an excellent choice. Here's how it's being approached:

- **Tracking Biomarkers**: Machine learning models can analyze changes in specific biomarkers from blood tests or imaging over time to detect signs of relapse or progression.
- **Patient-Specific Models**: Models are trained on individual patient data to predict their course of disease based on personal medical history.
- **Population-Based Patterns**: Models use data from broader patient populations to understand common patterns in disease progression and apply these insights to individual cases.

To compare with the entire multiple myeloma patient population, you'd need access to comprehensive datasets. These models can identify patterns such as common pathways of relapse or resistance to treatment. By analyzing these patterns, you could work on improving the models' ability to predict and interpret disease progression in individual patients.

## **ellie0237**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212467195678826506) 

 i would like to look more into the monitoring stage and how currently relapse or progression is being tracked using models. is there a way to compare with the whole multiple myeloma patient population and what are the patterns in disease progression?

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212466719197495346) 

 Machine learning models are being utilized at various stages in the cancer care continuum:

- **Diagnosis**: To detect cancer from medical images, lab results, or genetic information.
- **Prognosis**: To predict disease progression and patient outcomes.
- **Treatment Recommendation**: To suggest personalized treatment plans based on patient data.
- **Monitoring**: To track treatment response and detect signs of relapse or progression.

Each stage presents unique challenges for interpretability and accuracy, which are critical for clinical decision-making.

## **ellie0237**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212466716479721532) 

 what stage in the cancer diagnosis/treatment/observation are these models being used?

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212465692918681601) 

 Enhancing the interpretability of machine learning models in oncology, especially for complex diseases like multiple myeloma, is a multi-faceted challenge. Here are a few areas you could explore:

- **Model Transparency**: Utilizing models that are inherently more interpretable, like decision trees or linear regression, where the decision-making process is more transparent.
- **Post-hoc Interpretability**: Applying techniques that explain the predictions after the model has made them, such as LIME or SHAP values.
- **Visualization**: Developing visualization tools that can help clinicians see and understand the model's predictions and the factors influencing them.
- **Domain-specific Features**: Incorporating clinical expertise to select and engineer features that are meaningful and interpretable within the medical context.

These are just starting points. Researching and addressing gaps in any of these areas could make a significant impact on the field.

## **ellie0237**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212465690989043812) 

 i would love to discuss areas in which i could think about how to enhance their interpretability

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212465436936114327) 

 Machine learning models are increasingly being used in the diagnosis and prognosis of multiple myeloma. They help analyze large datasets from genomic profiles, imaging, and patient records to identify patterns that might not be apparent to humans. Their accuracy can vary, but there have been promising results in improving diagnosis, risk stratification, and treatment response predictions. The interpretability of these models is crucial, especially in a medical context, for clinicians to trust and understand the decisions made by the algorithms. Would you like to delve into the specifics of these models, or discuss how to enhance their interpretability?

## **ellie0237**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212465435216453732) 

 im interested in if any machine learning models are commonnly used in this process and if so how helopful and accurate they are?

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212465272653484092) 

 Hello! I'd be glad to discuss this with you. Current methods for diagnosing multiple myeloma typically include blood tests, urine tests, bone marrow biopsy, and imaging tests. Treatment often involves a combination of chemotherapy, corticosteroids, stem cell transplants, and targeted therapies. Is there a specific aspect you're interested in?

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212465267951542403) 

 Starting new chat with initial message:

> hey skelly! I would love to talk with you about the current methods being uses to diagnose adn treat cancers, particularly multiple myeloma

![chat-1212465264797687828.json](https://cdn.discordapp.com/attachments/1212465264797687828/1212468143671484436/chat-1212465264797687828.json?ex=6616dbf4&is=660466f4&hm=017185150962f117cae89e38da7b91f2dfa3135ec9ebbf8e37a48099816e6317&)

## **SkellyBot**:

 [message link](https://discord.com/channels/1194766712680222800/1212465264797687828/1212465265749524510) 

 

